Pharmaceutical Analysis & Statistics in Germany, May 2013 (p8)

You might be interested in: Therapeutics, Drug, Cancer, more »

211-260 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Evacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Evacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Evacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Evacetrapib (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Germany Hernia Repair Procedures Outlook to 2020

Germany Hernia Repair Procedures Outlook to 2020

  • $ 175
  • Industry report
  • July 2014
  • by Global Data

Germany Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "Germany Hernia Repair Procedures Outlook to 2020", provides key market data on the Germany Hernia Repair Procedures. The ...

  • Industries : Pathology
  • Countries : Germany
EU5 Hernia Repair Market Outlook to 2020

EU5 Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • July 2014
  • by Global Data

EU5 Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "EU5 Hernia Repair Market Outlook to 2020", provides key market data on the EU5 Hernia Repair market. The report provides value, ...

  • Industries : Pathology
  • Countries : United Kingdom, Spain, Italy, France, Germany, Europe
EU5 Hernia Repair Procedures Outlook to 2020

EU5 Hernia Repair Procedures Outlook to 2020

  • $ 450
  • Industry report
  • July 2014
  • by Global Data

EU5 Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "EU5 Hernia Repair Procedures Outlook to 2020", provides key market data on the Europe Hernia Repair Procedures. The report ...

  • Industries : Pathology
  • Countries : France, Germany, United Kingdom, Spain, Italy, Europe
Germany Hernia Repair Market Outlook to 2020

Germany Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Germany Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Germany Hernia Repair Market Outlook to 2020", provides key market data on the Germany Hernia Repair market. The report provides ...

  • Industries : Pathology
  • Countries : Germany
InterMed Discovery GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

InterMed Discovery GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary InterMed Discovery GmbH (InterMed Discovery) is a natural product lead discovery company based in Germany. It operates through its product segments, Pharmaceutical and food. The company develops ...

  • Industries : Pharmaceutical
  • Countries : Germany, Malaysia
Celonic GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celonic GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Celonic GmbH (Celonic) is a biotechnology company. The company provides contract manufacturing and analytics services for biopharmaceutical companies. Its services include the cell-line development, ...

  • Industries : Pharmaceutical
  • Countries : Germany
Mologen AG (MGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mologen AG (MGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary MOLOGEN AG (Mologen) is a biotechnology company. It researches and develops medicines in the fields of oncology and infectious diseases. The company develops drugs and vaccines based on technology ...

  • Industries : Pathology
  • Countries : Germany
Agennix AG (AGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Agennix AG (AGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Agennix AG (Agennix) is a bio-pharmaceutical company, based in Germany. The company develops novel therapies for critical care. It research and development program develops therapies in areas of ...

  • Industries : Pathology
  • Countries : Germany, United States
Paion AG (PA8) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paion AG (PA8) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Paion AG (PAION) is a biopharmaceutical company. It holds expertise in the development of anesthesia products and drugs for hospital based treatment. The company's product portfolio includes products ...

  • Industries : Pharmaceutical
  • Countries : Germany
The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

  • $ 3 013
  • Industry report
  • July 2014
  • by Visiongain

Report Details Where is the prostate cancer therapeutics market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Ou ...

  • Industries : Therapy
  • Countries : United States, World, South Korea, Europe, Brazil, Mexico, Italy, Japan, India, China, United Kingdom, Spain, Russian Federation, France, Germany
Pantec Biosolutions AG - Product Pipeline Analysis, 2014 Update

Pantec Biosolutions AG - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • July 2014
  • by Global Data

Summary Pantec Biosolutions AG (Pantec) is a transdermal drug delivery solution provider. The company develops transdermal drug delivery products using laser microporation technology. Its products include ...

  • Industries : Drug Delivery Technology
  • Countries : United States, Liechtenstein, Germany
JenaValve Technology GmbH - Product Pipeline Analysis, 2014 Update

JenaValve Technology GmbH - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • July 2014
  • by Global Data

Summary JenaValve Technology GmbH (JenaValve) is a medical device company. The company designs and develops minimally invasive heart valve replacement systems for the cardiovascular markets. It concentrates ...

  • Industries : Drug Discovery and Development
  • Countries : Argentina, Canada, Germany
ratiopharm GmbH SWOT Analysis, Strategy, Revenues and Profits

ratiopharm GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • July 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Germany
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World
EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • July 2014
  • by Global Data

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023 Summary Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences ...

  • Industries : Pathology
  • Countries : Germany, World, United States, Spain, United Kingdom, Italy, France, Japan
Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

  • $ 2 488
  • Industry report
  • July 2014
  • by MarketSizeInfo

This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth ...

  • Industries : Vitamin and Supplement
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, North America, Peru, Oman
MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Therapy
  • Countries : Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark
MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America
Bayer Healthcare Pharmaceuticals - Strategy and SWOT Report

Bayer Healthcare Pharmaceuticals - Strategy and SWOT Report

  • $ 175
  • Company report
  • June 2014
  • by MarketLine

Bayer Healthcare Pharmaceuticals - SWOT Analysis company profile is the essential source for top-level company data and information. Bayer Healthcare Pharmaceuticals - SWOT Analysis examines the company's ...

  • Industries : Pharmaceutical
  • Countries : Germany
Sandoz International GmbH - Strategy and SWOT Report

Sandoz International GmbH - Strategy and SWOT Report

  • $ 175
  • Company report
  • June 2014
  • by MarketLine

Sandoz International GmbH - SWOT Analysis company profile is the essential source for top-level company data and information. Sandoz International GmbH - SWOT Analysis examines the company's key business ...

  • Industries : Generic Drug
  • Countries : Germany
Abbott Laboratories - Strategy and SWOT Report

Abbott Laboratories - Strategy and SWOT Report

  • $ 175
  • Company report
  • June 2014
  • by MarketLine

Abbott Laboratories - SWOT Analysis company profile is the essential source for top-level company data and information. Abbott Laboratories - SWOT Analysis examines the company's key business structure ...

  • Industries : Generic Drug
  • Countries : United States, Netherlands, Canada, Spain, Italy, France, Germany, Japan
Intermittent Claudication - Pipeline Review, H1 2014

Intermittent Claudication - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Global Markets Direct

Intermittent Claudication - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Intermittent Claudication - Pipeline Review, H1 2014', provides an overview of the Intermittent Claudication's therapeutic ...

  • Industries : Drug Discovery and Development
  • Countries : South Korea, World, Germany, Israel
Global Proton Therapy Outlook 2018

Global Proton Therapy Outlook 2018

  • $ 2 000
  • Industry report
  • June 2014
  • by RNCOS

Proton Therapy, the new kid on the block for cancer treatment, has garnered worldwide attention in the past few years. Due to its ability to deliver higher doses of radiation to the targeted areas without ...

  • Industries : Therapy
  • Countries : Germany, China, Japan, World
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 4 995
  • Industry report
  • June 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business ...

  • Industries : Therapy
  • Countries : World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom
German Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

German Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary German Cancer Research Center (DKFZ) is a biomedical research institute. The company develops therapies for the treatment of cancer patients. It offers medical services, such as general medical ...

  • Industries : Pathology
  • Countries : Germany
PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, United Kingdom, Europe, World
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, United Kingdom, Europe, Oceania
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
About 300 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Germany

  • Findings of a Feasibility Study
  • October 2014
    7 pages
  • Pathology  

  • Germany  

View report >

Drug Industry In Germany

September 2014

9 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Select Products Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.